These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17893463)

  • 1. Opiate receptor revisited.
    Snyder SH
    Anesthesiology; 2007 Oct; 107(4):659-61. PubMed ID: 17893463
    [No Abstract]   [Full Text] [Related]  

  • 2. Delta opioid receptor selective alkaloid agonists and antagonists.
    Woods JH; DeCosta B; Jacobson AE; Rice KC; Medzihradsky F; Smith CB; Comer S; France CP; Winger G
    NIDA Res Monogr; 1989; 95():300-1. PubMed ID: 2561836
    [No Abstract]   [Full Text] [Related]  

  • 3. Permanent alterations of central opiate systems as a result of chronic opiate antagonism during infancy in rats.
    Diaz J; Paul L; Frenk H; Bailey B
    Proc West Pharmacol Soc; 1978; 21():377-9. PubMed ID: 211530
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of new compounds for opioid activity (1983).
    Woods JH; Winger GD; Medzihradsky F; Smith CB; Katz JL
    NIDA Res Monogr; 1984 Mar; 49():361-7. PubMed ID: 6090918
    [No Abstract]   [Full Text] [Related]  

  • 5. Opioid antagonists: structure activity relationships.
    Zimmerman DM; Leander JD
    NIDA Res Monogr; 1990; 96():50-60. PubMed ID: 2172827
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists.
    Fujii H; Watanabe A; Nemoto T; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
    Bioorg Med Chem Lett; 2009 Jan; 19(2):438-41. PubMed ID: 19042127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersensitivity to the behavioral effects of opiate antagonists [proceedings].
    Spealman RD; Kelleher RT; Morse WH; Goldberg SR
    Psychopharmacol Bull; 1981 Jan; 17(1):54-6. PubMed ID: 7232659
    [No Abstract]   [Full Text] [Related]  

  • 8. Selectivity of dynorphin for kappa opioid receptors.
    James IF; Chavkin C; Goldstein A
    Life Sci; 1982 Sep 20-27; 31(12-13):1331-4. PubMed ID: 6128656
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of selective tolerance to particular types of opiate receptors.
    Herz A; Schulz R; Wuster M
    NIDA Res Monogr; 1982 Apr; 41():215-22. PubMed ID: 6289118
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular aspects of pharmacological activity of naltrexone and naloxone].
    Golovko AI; Golovko SI; Leont'eva LV; Romanenko OI; Konoplin DA
    Eksp Klin Farmakol; 2003; 66(1):71-8. PubMed ID: 12683088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of opiate dependence.
    Villarreal JE; Herrera JE; Salazar LA
    Proc West Pharmacol Soc; 1985; 28():43-6. PubMed ID: 2999810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Opioid agonists and antagonists, opioid receptors].
    Holzgrabe U; Nachtsheim C; Siener T; Drosihn S; Brandt W
    Pharmazie; 1997 Jan; 52(1):4-22. PubMed ID: 9082464
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent analgesia in former opiate addicts is resistant to blockade of endogenous opioids.
    Liebmann PM; Lehofer M; Moser M; Hoehn-Saric R; Legl T; Pernhaupt G; Schauenstein K
    Biol Psychiatry; 1997 Nov; 42(10):962-4. PubMed ID: 9359985
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reversible binding of naloxazine and 14-hydroxydihydromorphazine with opiate receptors].
    Li LY; Ye CY; Zhang PW; Tian M; Jin YC
    Yao Xue Xue Bao; 1984 Apr; 19(4):251-5. PubMed ID: 6093431
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioid receptor antagonist promotes angiogenesis in bile duct ligated rats.
    Faramarzi N; Abbasi A; Tavangar SM; Mazouchi M; Dehpour AR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1226-9. PubMed ID: 19486259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanism of the action of opiate receptor antagonists in acute shock-induced blood loss].
    Sherman DM; Lafarenko VA
    Eksp Klin Farmakol; 1998; 61(1):25-9. PubMed ID: 9575407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lithium administration alters the interaction between opiate antagonists and opiate receptors in vivo.
    Amir S; Simantov R
    Neuropharmacology; 1981 Jun; 20(6):587-91. PubMed ID: 6264340
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose naltrexone: tricking the body to heal itself.
    Exp Biol Med (Maywood); 2011 Sep; 236(9):vii-viii. PubMed ID: 21991594
    [No Abstract]   [Full Text] [Related]  

  • 19. Naloxone enhancement of memory processes: effects of other opiate antagonists.
    Gallagher M
    Behav Neural Biol; 1982 Aug; 35(4):375-82. PubMed ID: 6299265
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural requirements for affinity and intrinsic activity at the opiate receptor defined in 4-phenylpiperidine and related series.
    Zimmeman DM; Smits SE; Hynes MD; Cantrell BE; Reamer M; Nickander R
    NIDA Res Monogr; 1982 Apr; 41():112-8. PubMed ID: 6289111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.